Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TXMD

+ Watchlist+ Portfolio

TherapeuticsMD, Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$1.91
52-Week Range
$1.43 – $2.95
Market Cap
$20.95M
P/E (TTM)
181.00
EPS (TTM)
0.01
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.76
PEG Ratio
—
Return on Equity
0.57%
Return on Assets
-2.31%
Gross Margin
100.00%
Operating Margin
-37.73%
Profit Margin
3.26%
Current Ratio
3.32
Debt/Equity
0.15
Total Debt
$4.21M
Free Cash Flow
$2.30M
Revenue Growth
60.60%
Earnings Growth
291.40%
Enterprise Value
$14.71M

Market Snapshot

About

TherapeuticsMD is a pharmaceutical company focused on developing and commercializing products for women, including hormone therapy, contraception, and other treatments. The company specializes in products addressing pregnancy prevention, menopause management, and reproductive health.